Atlas Trials

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

Clinical trial NCT03991299 · TERMINATED

Trial details

NCT number
NCT03991299
Sponsor
Vanderbilt University Medical Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ObeseDiabetes Mellitus, Type 2
Start date
2021-04-29
Primary completion
2022-02-11
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.